Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Comment by Alba1314on Nov 15, 2018 11:20am
81 Views
Post# 28980017

RE:RE:who s going to sell now?

RE:RE:who s going to sell now?I think "scam" is a bit severe. Personally, I think there are a lot of newbies invested in this stock who placed way too much emphasis on the release of the pharmakinetic data. Once it was announced that the study was positive, that's all that mattered. The pharma data that was promised was just the details of why the study was positive. But people were all moon eyed waiting for "the news!" of the pharma like it was going affect the sp. This is a penny bio stock. Comes down to financing and trial results. Not interest rates, or federal spending policy, or pharma data. That's why there was a runup when IMNP had a positive trial result: it moved ICO one step closer to making some $$$. You'll get little spikes of iinterested when the last pt in a study is dosed, but that's about it. 
<< Previous
Bullboard Posts
Next >>